Plasma olfactomedin 4 level in peripheral blood and its association with clinical features of breast cancer

  • Authors:
    • Chaoqian Liu
    • Yan Guo
    • Weiwei Wu
    • Zhenzhen Zhang
    • Lu Xu
    • Kainan Wu
    • Wei Hu
    • Guoping Liu
    • Junyi Shi
    • Cheng Xu
    • Jianwei Bi
    • Yuan Sheng
  • View Affiliations

  • Published online on: October 16, 2017     https://doi.org/10.3892/ol.2017.7193
  • Pages:8106-8113
0

Abstract

The present study aimed to investigate the expression of olfactomedin 4 (OLFM4) in plasma of patients with breast cancer and its association with diagnosis, metastasis and prognosis of breast cancer. OLFM4 gene expression level of peripheral blood plasma in 60 patients with breast cancer and 26 healthy donors was examined by ELISA. The expression of OLFM4 in tumor tissues of patients with breast cancer was evaluated by immunohistochemistry (protein expression) and reverse transcription‑quantitative polymerase chain reaction (mRNA expression), respectively. Circulating tumor cells (CTCs) were detected in a certain set of patients. The expression of OLFM4 in plasma of the overall healthy people was higher compared with patients with breast cancer. The plasma OLFM4 level in patients with breast cancer was consistent with the expression of OLFM4 protein in tumor tissues (R2=1), indicating that the level of plasma OLFM4 expression may represent the expression of OLFM4 in breast cancer tissues. The plasma OLFM4 level in patients with histological grade I was significantly lower compared with grade III (P<0.05). Breast cancer patients with positive CTC were associated with low level of plasma OLFM4. These results suggest that low OLFM4 expression in plasma or tissue specimens of breast cancer patients is more likely to represent low histological differentiation and decreased invasive/metastatic capabilities. Taken together, plasma OLFM4 level may be considered as a biomarker for diagnosis and prognosis of breast cancer for cases where there are difficulties in obtaining tumor tissue samples.

Related Articles

Journal Cover

December 2017
Volume 14 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

2016 Impact Factor: 1.39
Ranked #68/217 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Liu, C., Guo, Y., Wu, W., Zhang, Z., Xu, L., Wu, K. ... Sheng, Y. (2017). Plasma olfactomedin 4 level in peripheral blood and its association with clinical features of breast cancer. Oncology Letters, 14, 8106-8113. https://doi.org/10.3892/ol.2017.7193
MLA
Liu, C., Guo, Y., Wu, W., Zhang, Z., Xu, L., Wu, K., Hu, W., Liu, G., Shi, J., Xu, C., Bi, J., Sheng, Y."Plasma olfactomedin 4 level in peripheral blood and its association with clinical features of breast cancer". Oncology Letters 14.6 (2017): 8106-8113.
Chicago
Liu, C., Guo, Y., Wu, W., Zhang, Z., Xu, L., Wu, K., Hu, W., Liu, G., Shi, J., Xu, C., Bi, J., Sheng, Y."Plasma olfactomedin 4 level in peripheral blood and its association with clinical features of breast cancer". Oncology Letters 14, no. 6 (2017): 8106-8113. https://doi.org/10.3892/ol.2017.7193